Douglas K. Marks, MD, is a breast medical oncologist and director of the Clinical Trials Office, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, as well as associate professor in the Department of Medicine at NYU Grossman Long Island School of Medicine. As a phase 1 clinical trialist, he sees both patients with breast cancer and those who are looking to receive innovative treatments for their early-stage disease.
Throughout February, The American Journal of Managed Care® will be introducing its audience to the next generation of great thinkers and groundbreakers in health care. They represent the fields of oncology, public health, and managed care and are fast making their marks as key opinion leaders in their fields.
Douglas K. Marks, MD, is a breast medical oncologist and director of the Clinical Trials Office, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, and associate professor in the Department of Medicine at NYU Grossman Long Island School of Medicine in New York City. As a phase 1 clinical trialist, he sees both patients with breast cancer and those whose disease has already been treated but who are looking to receive innovative treatments for their early-stage disease.
“I've really enjoyed working with oncologists treating all types of different cancers, to similarly empower them to have the trials that they need for their patients,” Marks emphasizes. “And personally, as someone who is from Long Island, recognizing that the need is very high on Long Island—when you look at percentages of breast cancer incidence, we’re very high in the country—and helping to bring clinical trials. Also just helping to bring high-quality subspecialty breast cancer care to people's home communities.”
We hope you enjoy discovering more about Marks, his efforts to meet the great need for top-notch breast cancer care in his backyard, the goals he has set for himself and his patients, and why he believes it is important to have both clinical and academic career interests to excel and make a difference.
For the first interview in this series, with Chandler Cortina, MD, MS, FSSO, FACS, assistant professor of surgery and breast surgical oncologist at Froedtert & Medical College of Wisconsin, Milwaukee, please click here.
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Emergency Department Risk Model: Timely Identification of Patients for Outpatient Care Coordination
May 14th 2024The authors created a machine learning–based model to identify patients with major depressive disorder in the primary care setting at high risk of frequent emergency department visits, enabling prioritization for a care coordination program.
Read More